1. Add the template
Paste this content into My Templates, or start from a specialty-generated template and edit the sections.
Copy or download, then paste into Wavo under My Templates.
Oncology Follow-Up Note Cancer History / Context - Primary diagnosis, histology, stage, molecular markers as relevant, and current treatment intent. - Line of therapy and cycle day / days on oral therapy / time since last treatment or surgery/radiation. Interval History - Disease-related symptoms (pain, masses, cough, neurologic symptoms, bleeding, constitutional symptoms). - Treatment tolerance and toxicities by system (heme, GI, skin, neuropathy, endocrine, immune-related AEs). - Performance status change, hospitalizations, infections, transfusions, and supportive-care needs. - Adherence for oral therapies; missed doses and reasons. Data Reviewed - Labs (CBC, CMP, tumor markers), imaging/response assessment, pathology, and outside oncology records discussed today. - ECOG/Karnofsky if assessed. Exam - Focused exam including performance status, relevant nodes/masses, cardiopulmonary, and toxicity-related findings. Assessment - Disease status (responding / stable / progressing / NED on surveillance). - Treatment tolerance and active toxicities with grade if used. - Active supportive-care problems. Plan - Continue, hold, dose-reduce, delay, or change antineoplastic therapy with rationale. - Supportive medications, growth factors, infection workup, referrals (palliative care, radiation, surgery, cardio-onc). - Next imaging/labs, infusion scheduling, and precautions (fever neutropenia, irAE warning signs). - Goals-of-care or prognosis discussion if held today.
What makes the structure useful, and which visits it fits best.
Why this template works
Structural advantages for real documentation
Best for
Visit types and clinicians who use this format
Illustrative excerpt of how a visit can land in this structure. Not a real patient record—review and edit every note before signing.
Cancer Context Stage IIIA NSCLC, adenocarcinoma, PD-L1 60%, EGFR/ALK negative. Completing adjuvant pembrolizumab; currently cycle 8, day 1. Curative-intent pathway post-resection/chemo. Interval History Mild fatigue; no new cough, hemoptysis, or chest pain. Pruritus improved on topical steroid. No diarrhea, dyspnea, or vision changes. ECOG 1. Adherent; no missed doses. Data Reviewed CBC/CMP today acceptable for treatment. CT chest/abdomen/pelvis 3 weeks ago: no recurrence. TSH normal last month. Exam ECOG 1. Lungs clear, well-healed thoracotomy scar, no new lymphadenopathy. Skin: faint eczema antecubitals. Assessment NED on adjuvant pembrolizumab; well tolerated with mild dermatitis controlled. Plan Proceed with pembrolizumab today. Continue topical triamcinolone PRN. Educate on irAE red flags (severe diarrhea, SOB, chest pain, severe headache). Labs before next cycle. Restage imaging in ~3 months. Follow up next cycle; call clinic for fever ≥100.4 or new severe symptoms.
What the product actually does with your template.
Paste this content into My Templates, or start from a specialty-generated template and edit the sections.
Capture the encounter with ambient recording or dictation. Wavo structures the note using your template.
Edit with Smart Transform if needed, then export or copy into your EHR. You stay responsible for the final note.
Related templates
Continue exploring
Start free, paste the template, and see how Wavo documents in your structure.